Are you Dr. Dubey?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 22 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1600 Divisadero St
San Francisco, CA 94143Phone+1 415-353-9888Fax+1 415-353-7150
Summary
- Dr. Sarita Dubey, MD is an oncologist in San Francisco, California. She is currently licensed to practice medicine in California.
Education & Training
- University of Wisconsin Hospitals and ClinicsFellowship, Medical Oncology, 2001 - 2003
- Hennepin HealthcareResidency, Internal Medicine, 1998 - 2001
- Kilpauk Medical CollegeClass of 1994
Certifications & Licensure
- CA State Medical License 2006 - 2025
Clinical Trials
- Docetaxel, Carboplatin, and Bevacizumab in Treating Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer That Can Be Removed By Surgery Start of enrollment: 2005 Dec 01
- ASA404 in Combination With Carboplatin/Paclitaxel/Cetuximab in Treating Patients With Refractory Solid Tumors Start of enrollment: 2010 Jan 01
Publications & Presentations
PubMed
- 104 citationsAdjuvant atezolizumab versus placebo for patients with renal cell carcinoma at increased risk of recurrence following resection (IMmotion010): a multicentre, randomise...Sumanta Kumar Pal, Robert Uzzo, Jose Antonio Karam, Viraj A Master, Frede Donskov
Lancet. 2022-10-01 - 88 citationsFinal Overall Survival and Molecular Analysis in IMmotion151, a Phase 3 Trial Comparing Atezolizumab Plus Bevacizumab vs Sunitinib in Patients With Previously Untreate...Robert J Motzer, Thomas Powles, Michael B Atkins, Bernard Escudier, David F McDermott
JAMA Oncology. 2022-02-01 - 74 citationsCabozantinib in Combination With Atezolizumab for Advanced Renal Cell Carcinoma: Results From the COSMIC-021 StudySumanta K. Pal, Bradley Alexander McGregor, Cristina Suárez, Che-Kai Tsao, William Kevin Kelly
Journal of Clinical Oncology. 2021-09-07